Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place

Transplantation Proceedings

Volumn 37, Issue 1, 2005, Pages 159-161

  Lehle, K ^a   Birnbaum, D E ^a   Preuner, J G ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EVEROLIMUS; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SAPHENOUS VEIN; TRANSPLANTATION;

EID: 16244377483     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.140     Document Type: Conference Paper

References (12)

1. M. Haubitz, R. Brunkhorst Influence of a novel rapamycin analogon SDZ RAD on endothelial tissue factor and adhesion molecule expression Transplant Proc 34 2002 1124
2. J.M. Kovarik Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction Drugs Today 40 2004 101
3. A. Azzola, A. Havryk, P. Chhajed Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation Transplantation 77 2004 275
4. O.J. Cole, M. Shehata, K.M. Rigg Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model Transplant Proc 30 1998 2200
5. K. Lehle, J. Buttstaedt, D.E. Birnbaum Expression of adhesion molecules and cytokines in vitro by endothelial cells seeded on various polymer surfaces coated with titaniumcarboxonitride J Biomed Mater Res 65A 2003 393
6. P.J. Mohacsi, D. Tuller, B. Hulliger Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor J Heart Lung Transplant 16 1997 484
7. A. Farb, M. John, E. Acampado Oral everolimus inhibits in-stent neointimal growth Circulation 106 2002 2379
8. H.J. Eisen, E.M. Tuzcu, R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 829
9. H. Karlsson, L. Nassberger FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli Transplantation 64 1997 1217
10. B. Charreau, S. Coupel, F. Goret Association of glucocorticoids and cyclosporin A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNF-α-mediated endothelial cell activation Transplantation 69 2000 945
11. T. Kanda, T. Takahashi Interleukin-6 and cardiovascular disease Jpn Heart J 45 2004 183
12. D. Zohlnhöfer, T.G. Nuhrenberg, F.J. Neumann Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties Mol Pharmacol 65 2004 880